TEST BANK FOR PMHNP BOARDS FINAL
PAPER EXAMPREP COMPLETE QUESTIONS
AND ANSWERS VIEW AHEAD STUDY SHEET
◉ Brand Name. Answer: Name given by the drug manufacturer.
◉ Nonproprietary Name. Answer: Generic name provided by USAN
Council.
◉ United States Pharmacopoeia. Answer: Contains standards for
nutritional supplements.
◉ Drug Facts and Comparisons. Answer: Contains monographs for
all therapeutic class drugs.
◉ AHFS Drug Information. Answer: Monographs for nearly all
single-entity drugs.
◉ DailyMed. Answer: Comprehensive online resource for medicines.
◉ Drug Monographs. Answer: Detailed descriptions of drugs in a
class.
,◉ Natural Medicines Comprehensive Database. Answer: Evidence-
based info on herbal medicines.
◉ Drug Interaction Facts. Answer: Information on drug interactions.
◉ USP Dictionary of USAN. Answer: Compilation of drug names
and pronunciations.
◉ Martindale—The Complete Drug Reference. Answer:
Comprehensive drug reference for various medications.
◉ Nutritional Supplements. Answer: Products intended to supplement
diet.
◉ Clinical Judgment. Answer: Decision-making based on clinical
data.
◉ Patient Education. Answer: Information provided to patients about
medications.
◉ Cost Indices. Answer: Comparative pricing information for drugs.
◉ Dosage Forms. Answer: Forms in which drugs are available.
,◉ Therapeutic Uses. Answer: Approved and unapproved uses of
drugs.
◉ Healthcare Providers. Answer: Professionals who prescribe and
administer medications.
◉ Public Access. Answer: Availability of drug information to general
public.
◉ Safety. Answer: Considerations for preventing harm in drug use.
◉ Physiological Integrity. Answer: Maintaining bodily functions and
health.
◉ Federal Food, Drug, and Cosmetic Act. Answer: Legislation
authorizing FDA drug safety evaluation.
◉ Durham Humphrey Amendment. Answer: Defines prescription-
only drugs requiring medical supervision.
◉ Controlled Substances Act. Answer: Regulates controlled
substances and their categorization.
◉ Kefauver Harris Drug Amendment. Answer: Mandates drug
efficacy proof before marketing.
, ◉ Meperidine (Demerol). Answer: A Schedule II drug with high
abuse potential.
◉ Schedule I Drugs. Answer: High abuse potential, no medical use
recognized.
◉ Schedule II Drugs. Answer: High abuse potential, severe
dependence risk.
◉ Schedule III Drugs. Answer: Moderate abuse potential, dependence
risk exists.
◉ Schedule IV Drugs. Answer: Low abuse potential, limited
dependence risk.
◉ Fast Tracking. Answer: Expedited FDA process for urgent drug
approvals.
◉ Investigational New Drug Application. Answer: Application for
FDA approval of new drugs.
◉ Over-the-Counter (OTC) Drugs. Answer: Medications sold without
a prescription.
◉ USP NF. Answer: Official compendium listing drug standards.
PAPER EXAMPREP COMPLETE QUESTIONS
AND ANSWERS VIEW AHEAD STUDY SHEET
◉ Brand Name. Answer: Name given by the drug manufacturer.
◉ Nonproprietary Name. Answer: Generic name provided by USAN
Council.
◉ United States Pharmacopoeia. Answer: Contains standards for
nutritional supplements.
◉ Drug Facts and Comparisons. Answer: Contains monographs for
all therapeutic class drugs.
◉ AHFS Drug Information. Answer: Monographs for nearly all
single-entity drugs.
◉ DailyMed. Answer: Comprehensive online resource for medicines.
◉ Drug Monographs. Answer: Detailed descriptions of drugs in a
class.
,◉ Natural Medicines Comprehensive Database. Answer: Evidence-
based info on herbal medicines.
◉ Drug Interaction Facts. Answer: Information on drug interactions.
◉ USP Dictionary of USAN. Answer: Compilation of drug names
and pronunciations.
◉ Martindale—The Complete Drug Reference. Answer:
Comprehensive drug reference for various medications.
◉ Nutritional Supplements. Answer: Products intended to supplement
diet.
◉ Clinical Judgment. Answer: Decision-making based on clinical
data.
◉ Patient Education. Answer: Information provided to patients about
medications.
◉ Cost Indices. Answer: Comparative pricing information for drugs.
◉ Dosage Forms. Answer: Forms in which drugs are available.
,◉ Therapeutic Uses. Answer: Approved and unapproved uses of
drugs.
◉ Healthcare Providers. Answer: Professionals who prescribe and
administer medications.
◉ Public Access. Answer: Availability of drug information to general
public.
◉ Safety. Answer: Considerations for preventing harm in drug use.
◉ Physiological Integrity. Answer: Maintaining bodily functions and
health.
◉ Federal Food, Drug, and Cosmetic Act. Answer: Legislation
authorizing FDA drug safety evaluation.
◉ Durham Humphrey Amendment. Answer: Defines prescription-
only drugs requiring medical supervision.
◉ Controlled Substances Act. Answer: Regulates controlled
substances and their categorization.
◉ Kefauver Harris Drug Amendment. Answer: Mandates drug
efficacy proof before marketing.
, ◉ Meperidine (Demerol). Answer: A Schedule II drug with high
abuse potential.
◉ Schedule I Drugs. Answer: High abuse potential, no medical use
recognized.
◉ Schedule II Drugs. Answer: High abuse potential, severe
dependence risk.
◉ Schedule III Drugs. Answer: Moderate abuse potential, dependence
risk exists.
◉ Schedule IV Drugs. Answer: Low abuse potential, limited
dependence risk.
◉ Fast Tracking. Answer: Expedited FDA process for urgent drug
approvals.
◉ Investigational New Drug Application. Answer: Application for
FDA approval of new drugs.
◉ Over-the-Counter (OTC) Drugs. Answer: Medications sold without
a prescription.
◉ USP NF. Answer: Official compendium listing drug standards.
